TapImmune Announces the Filing of New Intellectual Property for its Platform Expression System Polystart

New Technology Significantly Enhances the Presentation of Desired Peptides on the Surface of Cells for Targeting to the Immune System March 20, 2014 TapImmune Inc., a clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease has filed a new patent application for a novel technology platform designed to enhance …